Search

Your search keyword '"Fanger, Gary R"' showing total 125 results

Search Constraints

Start Over You searched for: Author "Fanger, Gary R" Remove constraint Author: "Fanger, Gary R" Publication Year Range Last 50 years Remove constraint Publication Year Range: Last 50 years
125 results on '"Fanger, Gary R"'

Search Results

2. Enterococcus peptidoglycan remodeling promotes checkpoint inhibitor cancer immunotherapy.

7. Safety and activity of RRx-001 in patients with advanced cancer: a first-in-human, open-label, dose-escalation phase 1 study

10. List of Contributors

11. Episensitization

20. Mast cell tumor necrosis factor alpha production is regulated by MEK kinases

29. MEK kinase 1 gene disruption alters cell migration and c-Jun [NH.sub.2]-terminal kinase regulation but does not cause a measurable defect in NF-[Kappa]B activation

31. Abstract A1-35: RRx-001, a novel first in class epigenetic modulator, “episensitizes” colorectal patients to FOLFIRI: Preliminary resensitization data from the Phase 2 “ROCKET” study

34. Characterization of a Proapoptotic Antiganglioside GM2 Monoclonal Antibody and Evaluation of Its Therapeutic Effect on Melanoma and Small Cell Lung Carcinoma Xenografts

36. VSGP/F-Spondin: A New Ovarian Cancer Marker

39. P504S/α-Methylacyl-CoA Racemase

41. Detection of Mammaglobin in the Sera of Patients with Breast Cancer

42. P504S

43. MEK kinase 1 gene disruption alters cell migration and c-Jun NH 2 -terminal kinase regulation but does not cause a measurable defect in NF-κB activation

49. Follow the ATP: Tumor Energy Production: A Perspective

50. Analysis of Mutant Platelet-Derived Growth Factor Receptors Expressed in PC12 Cells Identifies Signals Governing Sodium Channel Induction during Neuronal Differentiation

Catalog

Books, media, physical & digital resources